menu
    • menu
    [{"orgOrder":0,"company":"GSK","sponsor":"Angelini Pharma","pharmaFlowCategory":"D","therapeuticArea":"Neurology","country":"UNITED KINGDOM","productType":"Small molecule","year":"2020","type":"Acquisition","leadProduct":"Camphor","moa":"TRPV1","graph1":"Neurology","graph2":"Approved","graph3":"GSK","amount2":0,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Cream","sponsorNew":"GSK \/ Angelini Pharma","highestDevelopmentStatusID":"12","companyTruncated":"GSK \/ Angelini Pharma"},{"orgOrder":0,"company":"Octavius Pharma Pvt. Ltd","sponsor":"Senta Pharma","pharmaFlowCategory":"DU","therapeuticArea":"Neurology","country":"","productType":"Small molecule","year":"2021","type":"Not Applicable","leadProduct":"Menthol","moa":"","graph1":"Neurology","graph2":"Approved","graph3":"Octavius Pharma Pvt. Ltd","amount2":0,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Topical Cream","sponsorNew":"Octavius Pharma Pvt. Ltd \/ Senta Pharma","highestDevelopmentStatusID":"12","companyTruncated":"Octavius Pharma Pvt. Ltd \/ Senta Pharma"},{"orgOrder":0,"company":"Innocan Pharma","sponsor":"Research Capital Corporation","pharmaFlowCategory":"D","therapeuticArea":"Neurology","country":"","productType":"Small molecule","year":"2023","type":"Private Placement","leadProduct":"Cannabidiol","moa":"","graph1":"Neurology","graph2":"Approved","graph3":"Innocan Pharma","amount2":0,"highestDevelopmentShortName":"Approved","therapeuticAreaShortName":"Neurology","amount2New":0,"dosageForm":"Spray","sponsorNew":"Innocan Pharma \/ Research Capital Corporation","highestDevelopmentStatusID":"12","companyTruncated":"Innocan Pharma \/ Research Capital Corporation"}]

    Find Clinical Drug Pipeline Developments & Deals for Menthol

    Menu

    Menthol

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls
    Filters Filter
    ×
    FILTER:
    filter
    Company Name
      filter

      Year

        filter

        DEALS // DEV.

          filter

          Country

            filter
            Sponsor
              filter

              Therapeutic Area

                filter

                Study Phase

                  filter

                  Deal Type

                    filter

                    Product Type

                      filter

                      Dosage Form

                        filter

                        Lead Product

                          filter

                          Target

                            Loading...
                            refresh Filters
                            refresh Reset Filter
                            refresh Reset Filter
                            price-trend All Developments

                            Therapeutic Area by Lead Product

                            Study Phase by Lead Product

                            Company by Lead Product

                            Top Deals by Deal Size (USD bn)

                            01

                            Octavius Pharma Pvt. Ltd

                            India
                            CPhI India 2024
                            Attending
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual BoothOctavius has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.

                            Lead Product(s) : Menthol,Camphor

                            Therapeutic Area : Neurology

                            Study Phase : Approved

                            Sponsor : Senta Pharma

                            Deal Size : Not Applicable

                            Deal Type : Not Applicable

                            DEALS_DEV arrow-down

                            Crampsal Cream (Pain Relief Cream) – Launched in Sudan

                            Details : Crampsal Cream (pain relieving oils) is a non-greasy pain relief cream with mixture of pain-relieving oils, menthol & camphor. It penetrates deep into the skin and provides long lasting relief.

                            Brand Name : Crampsal

                            Molecule Type : Small molecule

                            Upfront Cash : Not Applicable

                            November 29, 2021

                            Lead Product(s) : Menthol,Camphor

                            Therapeutic Area : Neurology

                            Highest Development Status : Approved

                            Sponsor : Senta Pharma

                            Deal Size : Not Applicable

                            Deal Type : Not Applicable

                            Octavius Pharma

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            02

                            Innocan Pharma

                            Israel arrow
                            The Pharmacy Technology
                            Not Confirmed

                            Innocan Pharma

                            Israel arrow
                            The Pharmacy Technology
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Cannabidiol,Menthol,Camphor

                            Therapeutic Area : Neurology

                            Study Phase : Approved

                            Sponsor : Research Capital Corporation

                            Deal Size : Undisclosed

                            Deal Type : Private Placement

                            DEALS_DEV arrow-down

                            Innocan Pharma Announces Closing of First Tranche Private Placement and Provides Corporate Update

                            Details : The Company intends to use the net proceeds from the Offering to fund the Company's pre-investigational new drug meeting with the United States FDA regarding the human application and expansion of the Company's derma-cosmetic product distribution.

                            Brand Name : Relief & Go

                            Molecule Type : Small molecule

                            Upfront Cash : Undisclosed

                            October 12, 2023

                            Lead Product(s) : Cannabidiol,Menthol,Camphor

                            Therapeutic Area : Neurology

                            Highest Development Status : Approved

                            Sponsor : Research Capital Corporation

                            Deal Size : Undisclosed

                            Deal Type : Private Placement

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth

                            03

                            GSK

                            United Kingdom arrow
                            The Pharmacy Technology
                            Not Confirmed

                            GSK

                            United Kingdom arrow
                            The Pharmacy Technology
                            Not Confirmed
                            • fda
                            • EDQM
                            • WHO-GMP
                            Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

                            Lead Product(s) : Camphor,Capsicum oleoresin,Menthol

                            Therapeutic Area : Neurology

                            Study Phase : Approved

                            Sponsor : Angelini Pharma

                            Deal Size : Undisclosed

                            Deal Type : Acquisition

                            DEALS_DEV arrow-down

                            Angelini Pharma Acquires ThermaCare® From GSK

                            Details : The acquired asset supports Angelini Pharma reinforcing both its Consumer Healthcare business and consolidating its International presence.

                            Brand Name : Undisclosed

                            Molecule Type : Small molecule

                            Upfront Cash : Undisclosed

                            March 10, 2020

                            Lead Product(s) : Camphor,Capsicum oleoresin,Menthol

                            Therapeutic Area : Neurology

                            Highest Development Status : Approved

                            Sponsor : Angelini Pharma

                            Deal Size : Undisclosed

                            Deal Type : Acquisition

                            blank

                            Stock Recap
                            #PipelineProspector

                            Data Compilation
                            #PharmaFlow

                            Virtual Booth